Printer Friendly

Magnetic therapy to treat chronic migraine developed.

Byline: ANI

Washington, Apr 30 (ANI): A new therapy that uses magnetic pulses has shown promise in treating chronic migraine sufferers, say researchers.

The new therapy is called transcranial magnetic stimulation, or TMS.

During the study conducted in rats, the University of California, San Francisco researchers focused on understanding the mechanism of action of TMS therapy -- how the treatment interacted with the brain to produce the pain-free outcomes of patients.

They identified potential opportunities to enhance treatment strategies in patients.

The study team noted that factors such as time and peak intensity of stimulation may be important components in the brain's response to TMS.

"The data demonstrate a biological rationale for the use of TMS to treat migraine aura," said Peter Goadsby, lead investigator of the study, professor and director of the UCSF Headache Centre.

"We found that cortical spreading depression, known as CSD and the animal correlate of migraine aura, was susceptible to TMS therapy, with the wave of neuronal excitation blocked on over 50 percent of occasions," he added.

The study showed that migraine aura, a condition in which a variety of mostly visual sensations come before or accompany the pain of a migraine attack, responds to magnetic stimulation.

The magnetic pulses block the wave of neuronal excitation, which is a biological system through which neurons become stimulated to fire.

TMS creates a focused magnetic pulse that passes noninvasively through the skull, inducing an electric current to disrupt the abnormal brain waves believed to be associated with migraine, including CSD. CSD in humans precedes migraine with aura.

The researchers hope that the findings give neurologists a potential new treatment option for migraine sufferers unable to tolerate medication.

The findings were presented during the annual American Academy of Neurology scientific meeting in Seattle. (ANI)

Copyright 2009 Asian News International (ANI) - All Rights Reserved.

Provided by an company
COPYRIGHT 2009 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:Apr 30, 2009
Previous Article:Pacifiers don't interfere with breastfeeding success.
Next Article:Heidi Klum didn't want to break pregnancy news so early.

Related Articles
Transformed migraine responds to levetiracetam.
Migraines & women.
Subclinical brain lesions in migraine mimic MS.
Limit triptans, analgesics to prevent drug-overuse headache.
Ask your pharmacist.
TMS shows efficacy for treating migraine with aura.
Closure of patent foramen ovale may reduce migraine occurrence, intensity.
Myths connect hypertension and headaches.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |